Is xenon really neuroprotective after cardiac arrest? [16]

Anesthesiology

Volumn 104, Issue 1, 2006, Pages 211-

  Fries, Michael ^a   Weis, Joachim ^a   Rossaint, Rolf ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCEROL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OPIATE; XENON; NEUROPROTECTIVE AGENT;

ANESTHESIA; BRAIN DAMAGE; DISEASE MARKER; DRUG INDICATION; DRUG MECHANISM; ENERGY METABOLISM; HEART ARREST; ISCHEMIA; LETTER; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RESUSCITATION; SUDDEN DEATH; SWINE; ANIMAL; BRAIN DISEASE; NOTE;

ANIMALS; BRAIN DISEASES; HEART ARREST; NEUROPROTECTIVE AGENTS; SWINE; XENON;

EID: 33644870552     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/00000542-200601000-00044     Document Type: Letter

References (12)

1. Wilhelm S, Ma D, Maze M, Franks NP: Effects of xenon on in vitro and in vivo models of neuronal injury. ANESTHESIOLOGY 2002; 96:1485-91
2. de Sousa SL, Dickinson R, Lieb WR, Franks NP: Contrasting synaptic actions of the inhalational general anesthetics isoflurane and xenon. ANESTHESIOLOGY 2000; 92:1055-66
3. Schmidt M, Marx T, Gloggl E, Reinelt H, Schirmer U: Xenon attenuates cerebral damage after ischemia in pigs. ANESTHESIOLOGY 2005; 102:929-36
4. de Vreede-Swagemakers JJ, Gorgels AP, Dubois-Arbouw WI, van Ree JW, Daemen MJ, Houben LG, Wellens HJ: Out-of-hospital cardiac arrest in the 1990's: A population-based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol 1997; 30:1500-5
5. Zheng ZJ, Croft JB, Giles WH: Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001; 104:2158-63
6. Wenzel V, Krismer AC, Arntz HR, Sitter H, Stadlbauer KH, Lindner KH, European Resuscitation Council Vasopressor during Cardiopulmonary Resuscitation Study Group: A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med 2004; 350:105-13
7. Radovsky A, Safar P, Sterz F, Leonov Y, Reich H, Kuboyama K: Regional prevalence and distribution of ischemic neurons in dog brains 96 hours after cardiac arrest of 0 to 20 minutes. Stroke 1995; 26:2127-33
8. Robergs RA, Griffin SE: Glycerol: Biochemistry, pharmacokinetics and clinical and practical applications. Sports Med 1998; 26:145-67
9. Berger C, Sakowitz OW, Kiening KL, Schwab S: Neurochemical monitoring of glycerol therapy in patients with ischemic brain edema. Stroke 2005; 36:e4-6
10. Gliemroth J, Klaus S, Bahlmann L, Klohn A, Duysen K, Reith A, Arnold H: Interstitial glycerol increase in microdialysis after glycerol enema. J Clin Neurosci 2004; 11:53-6
11. Murkin JM, Baird DL, Martzke JS, Yee R: Cognitive dysfunction after ventricular fibrillation during implantable cardioverter/defibrillator procedures is related to duration of the reperfusion interval. Anesth Analg 1997; 84:1186-92
12. Lim YJ, Zheng S, Zuo Z: Morphine preconditions Purkinje cells against cell death under in vitro simulated ischemia-reperfusion conditions. ANESTHESIOLOGY 2004; 100:562-8